Categories Earnings, Health Care

AbbVie (ABBV) Q4 earnings preview: Generic competition might weigh on results

With only a few weeks left for closing the high-value acquisition of Allergan, AbbVie (NYSE: ABBV) is busy doing the groundwork for the integration. The company will be unveiling its December-quarter results Friday before the opening bell.

AbbVie (NYSE: ABBV) Q3 2019 Earnings Review

It is widely expected that earnings will rise 6% year-over-year to $2.19 per share, which falls at the upper end of the management’s guidance range. The bottom-line exceeded estimates in three of the trailing four quarters and the positive trend is likely to continue. The consensus estimate for December-quarter revenue is $8.7 billion, which represents a 5% increase.

Humira Slowdown

Of late, AbbVie’s sales have been negatively impacted by generic competition to its flagship product Humira, especially in the overseas market. However, the drug’s relatively stable demand in the U.S. will likely support top-line growth in the to-be-reported quarter.

Related: AbbVie Q3 2019 Earnings Conference Call Transcript

Mavyret, AbbVie’s HCV drugs that registered weak sales most of last year due to competition, might not contribute much to the results. Another factor that affects sales is unfavorable pricing.

Product Mix

On the positive side, the oncology segment has witnessed stable sales growth in the past, mainly for Imbruvica and Venclexta, which will likely continue this time. Also, initial estimates indicate that the company’s plaque-psoriasis drug Skyrizi and arthritis therapy Rinvoq have been doing well since their launch. Since these products are crucial for driving future growth, the market will be keeping a tab on their fourth-quarter performance.

Looking Back

In the third quarter, revenues moved up to $8.5 billion as weakness in the core Immunology segment was more than offset by a strong performance by the Hematologic Oncology unit. Consequently, adjusted earnings increased 9% annually to $2.33 per share and topped expectations.

The company this week said it achieved positive results from an advanced-stage clinical trial on Rinvoq for the treatment of psoriatic arthritis. The drug reportedly met both the primary and secondary endpoints of the study. It is expected to offset the impact of the ongoing slowdown in the sales of Humira.

Also see: Merck & Co. Q4 earnings beat estimates; revenue misses

After underperforming the market for most of 2019, AbbVie shares entered 2020 on a low note. The stock slipped to a three-month low last month but has been regaining strength since then.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips

Most Popular

Kin Insurance’s strategy is focused on growing in catastrophe-exposed states: CEO Sean Harper

Kin Insurance is a leading insurance technology company specialized in high-risk residential areas. The direct-to-consumer business model and use of advanced technology allow the company to offer affordable pricing without

Infographic: Key highlights from Best Buy (BBY) Q1 2023 earnings results

Best Buy Co., Inc. (NYSE: BBY) reported first quarter 2023 earnings results today. Enterprise revenue dropped to $10.6 billion from $11.6 billion in the year-ago period. Comparable sales were down

AutoZone (AZO) Q3 Earnings: Key financials and quarterly highlights

AutoZone, Inc. (NYSE: AZO) reported third quarter 2022 earnings results today. Net sales increased 5.9% year-over-year to $3.9 billion. Domestic same-store sales increased 2.6%. Net income decreased 0.6% to $592.6 million, while

Comments

  1. Pingback: ไฮโล
  2. Pingback: Heavy
  3. Pingback: Heavy R
  4. Pingback: ThopTV APK
  5. Pingback: ff tool
  6. Pingback: ff tools hack
  7. Pingback: clearance
  8. Pingback: bauck
  9. Pingback: FFH4X APK
  10. Pingback: Epaviste gratuit
  11. Pingback: Epaviste
  12. Pingback: enlevement epave
  13. Pingback: Epaviste
  14. Pingback: Epaviste
  15. Pingback: Epaviste gratuit
  16. Pingback: enlevement epave
  17. Pingback: épave automobile
  18. Pingback: Epaviste
  19. Pingback: Epaviste gratuit
  20. Pingback: enlevement epave
  21. Pingback: Epaviste
  22. Pingback: Epaviste
  23. Pingback: enlevement epave
  24. Pingback: épave automobile
  25. Pingback: เว็บ123
  26. Pingback: คาสิโน
  27. Pingback: thc edibles
  28. Pingback: ps5 on sale
  29. Pingback: Epaviste gratuit
  30. Pingback: pink runtz
  31. Pingback: CZ P10C FOR SALE
  32. Pingback: Glock 43x for Sale

Comments are closed.

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top